Magic Peptide: Unique Properties of the LRR11 Peptide in the Activation of Leukotriene Synthesis in Human Neutrophils

Int J Mol Sci. 2021 Mar 6;22(5):2671. doi: 10.3390/ijms22052671.

Abstract

Neutrophil-mediated innate host defense mechanisms include pathogen elimination through bacterial phagocytosis, which activates the 5-lipoxygenase (5-LOX) product synthesis. Here, we studied the effect of synthetic oligodeoxyribonucleotides (ODNs), which mimic the receptor-recognized sites of bacterial (CpG-ODNs) and genomic (G-rich ODNs) DNAs released from the inflammatory area, on the neutrophil functions after cell stimulation with Salmonella typhimurium. A possible mechanism for ODN recognition by Toll-like receptor 9 (TLR9) and RAGE receptor has been proposed. We found for the first time that the combination of the magic peptide LRR11 from the leucine-rich repeat (LRR) of TLR9 with the CpG-ODNs modulates the uptake and signaling from ODNs, in particular, dramatically stimulates 5-LOX pathway. Using thickness shear mode acoustic method, we confirmed the specific binding of CpG-ODNs, but not G-rich ODN, to LRR11. The RAGE receptor has been shown to play an important role in promoting ODN uptake. Thus, FPS-ZM1, a high-affinity RAGE inhibitor, suppresses the synthesis of 5-LOX products and reduces the uptake of ODNs by neutrophils; the inhibitor effect being abolished by the addition of LRR11. The results obtained revealed that the studied peptide-ODN complexes possess high biological activity and can be promising for the development of effective vaccine adjuvants and antimicrobial therapeutics.

Keywords: LRR11; Langmuir isotherm; acoustic method; leukotriene; neutrophil; oligodeoxyribonucleotides.

MeSH terms

  • Arachidonate 5-Lipoxygenase / metabolism*
  • Benzamides / pharmacology
  • Calcium / metabolism
  • CpG Islands
  • Enzyme Activation / drug effects
  • Humans
  • Kinetics
  • Leukotrienes / biosynthesis*
  • Neutrophils / drug effects
  • Neutrophils / metabolism*
  • Oligodeoxyribonucleotides / chemical synthesis
  • Oligodeoxyribonucleotides / pharmacology
  • Opsonin Proteins
  • Peptide Fragments / pharmacology*
  • Reactive Oxygen Species / metabolism
  • Receptor for Advanced Glycation End Products / antagonists & inhibitors
  • Salmonella typhimurium
  • Toll-Like Receptor 9 / physiology*

Substances

  • AGER protein, human
  • Benzamides
  • FPS-ZM1
  • Leukotrienes
  • Oligodeoxyribonucleotides
  • Opsonin Proteins
  • Peptide Fragments
  • Reactive Oxygen Species
  • Receptor for Advanced Glycation End Products
  • TLR9 protein, human
  • Toll-Like Receptor 9
  • Arachidonate 5-Lipoxygenase
  • ALOX5 protein, human
  • Calcium